6 November 2026
Posting of Annual Report and Notice of AGM
Bioventix plc
(“Bioventix” or the “Company”)
Posting of Annual Report and Notice of AGM
Bioventix plc (AIM: BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that it has posted its Annual Report for the year ended 30 June 2026 together with a Notice of Annual General Meeting (“AGM”) and Form of Proxy to shareholders that have elected to receive documentation in hard copy format. The documents will also be available to download in PDF format below:
The Company’s AGM will be held at Farnham Castle, Farnham, Surrey, GU9 0AG on Thursday 3 December 2026 at 2.00pm.
For further information please contact:
| Bioventix plc | Tel: 01252 728 001 | |
| Peter Harrison | Chief Executive Officer | |
| Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |
| Geoff Nash/Elysia Bough | Corporate Finance | |
| Nigel Birks/Harriet Ward | ECM | |